Literature DB >> 9146528

Human papillomavirus-associated tumors of the skin and mucosa.

S Majewski1, S Jablonska.   

Abstract

This review discusses diseases of the lower genital tract in which the presence of human papillomavirus (HPV) DNA is well documented. We discuss epidemiologic, clinical, and experimental data supporting a causative role for HPV in mucosal malignancies, with emphasis on the role of viral and host factors in their pathogenesis. Of special interest is the recently discovered association of cutaneous tumors with HPVs, previously known only for tumors in epidermodysplasia verruciformis (EV). The frequent detection of EV-specific or EV-related HPVs in immunosuppressed persons and in cutaneous tumors in the general population supports the importance of EV as a model of cutaneous oncogenesis. We also discuss recent serologic findings based on enzyme-linked immunosorbent assay results with the use of viruslike particles. This is important both for detection of present or past HPV infection and for epidemiologic and immunologic studies. Novel therapeutic modalities for HPV tumors and prospects for prophylactic and therapeutic vaccination are presented.

Entities:  

Mesh:

Year:  1997        PMID: 9146528     DOI: 10.1016/s0190-9622(97)80315-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  17 in total

Review 1.  Progress and prospects for L2-based human papillomavirus vaccines.

Authors:  Rosie T Jiang; Christina Schellenbacher; Bryce Chackerian; Richard B S Roden
Journal:  Expert Rev Vaccines       Date:  2016-03-10       Impact factor: 5.217

2.  Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors.

Authors:  Tsuyoshi Mitsuishi; Yukie Iwabu; Kenzo Tokunaga; Tetsutaro Sata; Takehiko Kaneko; Kuniaki Ohara; Ikuroh Ohsawa; Fumino Oda; Yuko Yamada; Seiji Kawana; Kohji Ozaki; Mayuka Nakatake; Osamu Yamada
Journal:  BMC Cancer       Date:  2010-03-27       Impact factor: 4.430

3.  Surgical treatment for 11 cases of penile verrucous carcinoma.

Authors:  Sun Chuanyu; Xu Ke; Zheng Jie; Xia Guowei; Fang Zujun; Ding Qiang
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

4.  Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts.

Authors:  G Gross; H Pfister
Journal:  Med Microbiol Immunol       Date:  2003-06-28       Impact factor: 3.402

Review 5.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

6.  Complete Healing of a Giant Wart in a Severely Immune-Compromised Patient with HIV Infection Treated with Acupuncture.

Authors:  T Ursini; E Polilli; G Congedo; M Tontodonati; F Di Masi; E Mazzotta; G Parruti; L Pippa
Journal:  Case Rep Dermatol       Date:  2011-08-16

7.  P2X(5) and P2X(7) receptors in human warts and CIN-612 organotypic raft cultures of human papillomavirus infected keratinocytes.

Authors:  Aina V H Greig; Scott Cuthill; Claire Linge; Elizabeth Clayton; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2006-08-11       Impact factor: 3.765

8.  Pembrolizumab in FIGO IVB Verrucous Carcinoma of the Vulva: A Case Report.

Authors:  Yuhan Wang; Rongchun Lin; Bingzhong Zhang; Hui Zhou; Zhongqiu Lin; Tingting Yao
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

9.  Verrucous carcinoma of the vulva: a case report.

Authors:  Ioannis Boutas; Chrisostomos Sofoudis; Emmanouil Kalampokas; Christos Anastasopoulos; Theodoros Kalampokas; Nikolaos Salakos
Journal:  Case Rep Obstet Gynecol       Date:  2013-01-16

10.  Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses.

Authors:  Ines Schneider; Mandy D Lehmann; Vlada Kogosov; Eggert Stockfleth; Ingo Nindl
Journal:  BMC Infect Dis       Date:  2013-04-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.